Literature DB >> 25461353

Management of presumed benign ovarian tumors: updated French guidelines.

J-L Brun1, X Fritel2, Y Aubard3, B Borghese4, N Bourdel5, N Chabbert-Buffet6, P Collinet7, X Deffieux8, G Dubernard9, C Huchon10, N Kalfa11, N Lahlou12, H Marret13, C Pienkowski14, H Sevestre15, I Thomassin-Naggara16, J Levêque17.   

Abstract

Transvaginal pelvic ultrasound is the first-line imaging examination for presumed benign ovarian tumors (PBOT) in adult women (Grade A). Ultrasound is sufficient for characterizing a unilocular anechoic cyst smaller than 7cm (Grade A). Magnetic resonance imaging is the recommended second-line investigation for indeterminate masses or masses larger than 7cm (Grade B). Serum CA-125 assay is not recommended for first-line diagnosis in adult women (Grade C). In women with a unilocular anechoic cyst, hormone therapy is ineffective and not recommended (Grade A). Ultrasound-guided aspiration is not recommended (Grade B). Abstention is an option in adult women with a unilocular asymptomatic anechoic cyst smaller than 10cm and no history of cancer (Grade B). If symptoms develop, laparoscopy is the gold standard for surgical treatment of PBOT (Grade A). Conservative surgical treatment (cystectomy) should be preferred to oophorectomy in pre-menopausal women without a previous history of cancer (Grade C). In cases of suspected adnexal torsion, laparoscopic surgical exploration is recommended (Grade B). Conservative treatment or detorsion without oophorectomy is recommended for pre-menopausal women regardless of the estimated torsion duration and macroscopic appearance of the ovary (Grade B). During pregnancy, expectant management is recommended for unilocular asymptomatic anechoic cysts smaller than 6cm (Grade C).
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Imaging; Ovarian cyst; Pregnancy; Treatment

Mesh:

Substances:

Year:  2014        PMID: 25461353     DOI: 10.1016/j.ejogrb.2014.10.012

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Ovarian torsion caused by hyperreactio luteinalis in the third trimester of pregnancy: a case report.

Authors:  Qin Li; Xiaotian Li; Pengnan Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Mucinous Cystadenoma Causing Abdominal Distension: A Case Report.

Authors:  Alexandra M Craen; David Lebowitz; Kendra Amico; Latha Ganti
Journal:  Cureus       Date:  2018-11-30

3.  Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial.

Authors:  Vincent Dochez; Mélanie Randet; Céline Renaudeau; Jérôme Dimet; Aurélie Le Thuaut; Norbert Winer; Thibault Thubert; Edouard Vaucel; Hélène Caillon; Guillaume Ducarme
Journal:  J Clin Med       Date:  2019-10-25       Impact factor: 4.241

4.  A strengthening the reporting of observational studies in epidemiology (STROBE): Are HE4 and CA 125 suitable to detect a Paget disease of the vulva?

Authors:  Miriam Dellino; Giulio Gargano; Raffele Tinelli; Carmine Carriero; Carla Minoia; Skrypets Tetania; Erica Silvestris; Vera Loizzi; Angelo Paradiso; Porzia Casamassima; Antonio Tufaro; Gennaro Cormio; Vito Michele Garrisi
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.